+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-07-04Number of Pages: 167

HIV/AIDS Diagnostics Market (Product - Kits and Reagents and Instruments; Test Type - Rapid Tests (POC), ELISA, and Nucleic Acid Tests; End User - Hospitals, Private Diagnostic Laboratories, and Academic and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global HIV/AIDS Diagnostics Market: Snapshot

Competition in the global HIV/AIDS diagnostics market is moderate. This is because there are just a few big players who have a stronghold over the market and barriers to entry are high for aspiring players on account of the exhaustive research procedures involved in the development of diagnostic kits. In the next couple of years, the competition is predicted to heat up on account of the competitive pricing strategy leveraged by savvy companies in the market.

In order to expand further, most of the prominent players in the global HIV/AIDS diagnostics market have banked upon carefully considered mergers and acquisitions and launch of better products. Driving growth in the market is the increasing instances of the HIV and the various initiatives adopted by government agencies and other non-profit organizations to generate awareness about HIV.

Serving to slowdown the global HIV/AIDS diagnostics market, on the other hand, is the lack of manifestation of symptoms in many cases of HIV. Sometimes, it even takes over 10 years for an HIV afflicted person to realize the existence and proliferation of the virus inside him that destroys his/her immune system.

A report by Transparency Market Research forecasts the global HIV/AIDS diagnostics market to expand at a 9.3% CAGR between 2017 and 2025 to become worth US$5.74 bn by 2025 from US$2.606 bn in 2016.

hiv aids diagnostics market

 

Nucleic Acid Test Segment to Outpace Others Due to Ability to Confirm Acute HIV Infections

Depending upon the type of tests, the global HIV/AIDS diagnostics market can be segmented into rapid tests (POC), ELISA, nucleic acid test, and others. Currently, the rapid test (POC) segment leads the market with a dominant share. In 2016, it held a substantial 58.6% share in the market, and,s going forward, it will likely increase that share marginally to 59.1% in 2025 by expanding at a CAGR of 9.4%. The rapid test (POC) segment was worth US1.526 in 2016 and is slated to attain a value of US$3.392 bn by 2025. This test has been seeing impressive take-up on account of the quick and accurate results it accords, its hassle-free use, and its affordability.

In terms of growth rate, however, the segment of nucleic acid test is predicted to surpass all others by registering a CAGR of 9.5% between 2017 and 2025. The growth in the segment is brought about by their use in confirming acute cases of HIV infections by uncovering the presence of HIV RNA in human serum and plasma samples.

Awareness Campaigns Propel North America Market to the Forefront

From a geographical standpoint, North America is a dominant player in the global HIV/AIDS diagnostics market which accounted for a share of 36.2% in the 2016. Rising at a CAGR of 8.7% from 2017 to 2025, the market in the region is expected to become worth US$1.964 bn by 2025. Some of the factors catalyzing growth in the North America market are the increasing knowledge about the diagnosis, awareness and other campaigns carried out by the government and other non-profit institutes, and the strong research and development facilities. The region is primarily powered the U.S.

Asia Pacific, on the other hand, is slated to outpace all other regions in terms of growth rate in the global HIV/AIDS diagnostics market because of high sero-prevalence of HIV in South and East Asia. It is projected to rise at a CAGR of 10.9% between 2017 and 2025.

Some of the prominent players operating in the global HIV/AIDS diagnostics market are F. Hoffman-La Roche Ltd., Alere, Abbott Laboratories, OraSure Technologies, Inc., Becton, Dickinson and Company, and Siemens Healthineers. 

1. Preface
      1.1. Market Definition and Scope
      1.2. Market Segmentation
      1.3. Key Research Objectives
      1.4. Research Highlights
 
2. Assumptions and Research Methodology
 
3. Executive Summary: Global HIV/AIDS Diagnostics Market
 
4. Market Overview
      4.1. Introduction
             4.1.1. Product Definition
             4.1.2. Industry Evolution / Developments
      4.2. Market Dynamics
             4.2.1. Drivers
                           4.2.1.1. Economic Drivers
                           4.2.1.2. Supply Side Drivers
                           4.2.1.3. Demand Side Drivers
             4.2.2. Restraints
             4.2.3. Opportunities
             4.2.4. Key Trends
 
5. Global HIV/AIDS Diagnostics Market Analysis and Forecast, 2017-2025
      5.1. Market Revenue Projections (US$ Mn)
      5.2. Porter’s Five forces Analysis: Global HIV/AIDS Diagnostics Market
      5.3. Recent Development (Industry Updates, Merger & Acquisition) 
      5.4. Global HIV/AIDS Epidemiology
      5.5. Disease Overview
      5.6. Preventive Measures for HIV/AIDS
      5.7. Future Market Outlook
 
6. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By Product Type
      6.1. Introduction & Definition
      6.2. Key Findings / Developments
      6.3. Market Value (US$ Mn) Forecast By Product Type
             6.3.1. Kits and Reagents
             6.3.2. Instruments
             6.3.3. Others
      6.4. Market Attractiveness by Product Type
 
7. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By Test Type
      7.1. Introduction & Definition
      7.2. Key Findings / Developments
      7.3. Market Value (US$ Mn) Forecast By Test Type
             7.3.1. Rapid Tests (POC)
             7.3.2. ELISA
             7.3.3. Nucleic Acid Tests
             7.3.4. Others 
      7.4. Market Attractiveness by Test Type
 
8. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By End User
      8.1. Introduction & Definition
      8.2. Key Findings / Developments
      8.3. Market Value (US$ Mn) Forecast By End User
             8.3.1. Hospitals and Clinics
             8.3.2. Private Diagnostic Laboratories
             8.3.3. Academic and Research Institutes
             8.3.4. Others 
      8.4. Market Attractiveness by End User
 
9. Global HIV/AIDS Diagnostics Market Analysis and Forecasts, By Region
      9.1. Key Findings
      9.2. Market Value (US$ Mn) Forecast By Region
             9.2.1. North America
             9.2.2. Europe
             9.2.3. Asia Pacific
             9.2.4. Latin America
             9.2.5. Middle East and Africa
      9.3. Market Attractiveness by Region
 
10. North America HIV/AIDS Diagnostics Market Analysis and Forecast
      10.1. Key Findings
      10.2. Market Value (US$ Mn) Forecast By Country
             10.2.1. U.S.
             10.2.2. Canada
      10.3. Market Value (US$ Mn) Forecast By Product Type
             10.3.1. Kits and Reagents
             10.3.2. Instruments
             10.3.3. Others
      10.4. Market Value (US$ Mn) Forecast By Test Type
             10.4.1. Rapid Tests (POC)
             10.4.2. ELISA
             10.4.3. Nucleic Acid Tests
             10.4.4. Others 
      10.5. Market Value (US$ Mn) Forecast By End User
             10.5.1. Hospitals and Clinics
             10.5.2. Private Diagnostic Laboratories
             10.5.3. Academic and Research Institutes
             10.5.4. Others 
      10.6. Market Attractiveness Analysis 
             10.6.1. By Country
             10.6.2. By Product Type
             10.6.3. By Test Type
             10.6.4. By End User
 
11. Europe HIV/AIDS Diagnostics Market Analysis and Forecast
      11.1. Key Findings
      11.2. Market Value (US$ Mn) Forecast By Country
             11.2.1. Germany
             11.2.2. U.K.
             11.2.3. France
             11.2.4. Spain
             11.2.5. Italy
             11.2.6. Rest of Europe
      11.3. Market Value (US$ Mn) Forecast By Product Type
             11.3.1. Kits and Reagents
             11.3.2. Instruments
             11.3.3. Others
      11.4. Market Value (US$ Mn) Forecast By Test Type
             11.4.1. Rapid Tests (POC)
             11.4.2. ELISA
             11.4.3. Nucleic Acid Tests
             11.4.4. Others 
      11.5. Market Value (US$ Mn) Forecast By End User
             11.5.1. Hospitals and Clinics
             11.5.2. Private Diagnostic Laboratories
             11.5.3. Academic and Research Institutes
             11.5.4. Others 
      11.6. Market Attractiveness Analysis 
             11.6.1. By Country
             11.6.2. By Product Type
             11.6.3. By Test Type
             11.6.4. By End User
 
12. Asia Pacific HIV/AIDS Diagnostics Market Analysis and Forecast
      12.1. Key Findings
      12.2. Market Value (US$ Mn) Forecast By Country
             12.2.1. China
             12.2.2. Japan
             12.2.3. India
             12.2.4. Australia & New Zealand
             12.2.5. Rest of Asia Pacific
      12.3. Market Value (US$ Mn) Forecast By Product Type
             12.3.1. Kits and Reagents
             12.3.2. Instruments
             12.3.3. Others
      12.4. Market Value (US$ Mn) Forecast By Test Type
             12.4.1. Rapid Tests (POC)
             12.4.2. ELISA
             12.4.3. Nucleic Acid Tests
             12.4.4. Others 
      12.5. Market Value (US$ Mn) Forecast By End User
             12.5.2. Private Diagnostic Laboratories
             12.5.3. Academic and Research Institutes
             12.5.4. Others 
      12.6. Market Attractiveness Analysis 
             12.6.1. By Country
             12.6.2. By Product Type
             12.6.3. By Test Type
             12.6.4. By End User
 
13. Latin America HIV/AIDS Diagnostics Market Analysis and Forecast
      13.1. Key Findings
      13.2. Market Value (US$ Mn) Forecast By Country
             13.2.1. Brazil
             13.2.2. Mexico
             13.2.3. Rest of Latin America
      13.3. Market Value (US$ Mn) Forecast By Product Type
             13.3.1. Kits and Reagents
             13.3.2. Instruments
             13.3.3. Others
      13.4. Market Value (US$ Mn) Forecast By Test Type
             13.4.1. Rapid Tests (POC)
             13.4.2. ELISA
             13.4.3. Nucleic Acid Tests
             13.4.4. Others 
      13.5. Market Value (US$ Mn) Forecast By End User
             13.5.1. Hospitals and Clinics
             13.5.2. Private Diagnostic Laboratories
             13.5.3. Academic and Research Institutes
             13.5.4. Others 
      13.6. Market Attractiveness Analysis 
             13.6.1. By Country
             13.6.2. By Product Type
             13.6.3. By Test Type
             13.6.4. By End User
 
14. Middle East and Africa HIV/AIDS Diagnostics Market Analysis and Forecast
      14.1. Key Findings
      14.2. Market Value (US$ Mn) Forecast By Country
             14.2.1. Saudi Arabia
             14.2.2. South Africa
             14.2.3. Rest of MEA
      14.3. Market Value (US$ Mn) Forecast By Product Type
             14.3.1. Kits and Reagents
             14.3.2. Instruments
             14.3.3. Others
      14.4. Market Value (US$ Mn) Forecast By Test Type
             14.4.1. Rapid Tests (POC)
             14.4.2. ELISA
             14.4.3. Nucleic Acid Tests
             14.4.4. Others 
      14.5. Market Value (US$ Mn) Forecast By End User
             14.5.1. Hospitals and Clinics
             14.5.2. Private Diagnostic Laboratories
             14.5.3. Academic and Research Institutes
             14.5.4. Others 
      14.6. Market Attractiveness Analysis 
             14.6.1. By Country
             14.6.2. By Product Type
             14.6.3. By Test Type
             14.6.4. By End User
 
15. Competition Landscape
      15.1. Market Player- Competition Matrix
      15.2. Market Share Analysis by Company (2016)
      15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
             15.3.1. F. Hoffmann-La Roche Ltd. 
                       15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.1.2 Product Portfolio
                       15.3.1.3 SWOT Analysis
                       15.3.1.4 Financial Overview
                       15.3.1.5 Strategic Overview
             15.3.2. Hologic, Inc. 
                       15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.2.2 Product Portfolio
                       15.3.2.3 SWOT Analysis
                       15.3.2.4 Financial Overview
                       15.3.2.5 Strategic Overview
             15.3.3. Alere, Inc.
                       15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.3.2 Product Portfolio
                       15.3.3.3 SWOT Analysis
                       15.3.3.4 Financial Overview
                       15.3.3.5 Strategic Overview
             15.3.4. Bio-Rad Laboratories
                       15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.4.2 Product Portfolio
                       15.3.4.3 SWOT Analysis
                       15.3.4.4 Financial Overview
                       15.3.4.5 Strategic Overview
             15.3.5. Abbott Laboratories 
                       15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.5.2 Product Portfolio
                       15.3.5.3 SWOT Analysis
                       15.3.5.4 Financial Overview
                       15.3.5.5 Strategic Overview
             15.3.6. Siemens Healthineers 
                       15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.6.2 Product Portfolio
                       15.3.6.3 SWOT Analysis
                       15.3.6.4 Financial Overview
                       15.3.6.5 Strategic Overview
             15.3.7. OraSure Technologies, Inc.
                       15.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.7.2 Product Portfolio
                       15.3.7.3 SWOT Analysis
                       15.3.7.4 Financial Overview
                       15.3.7.5 Strategic Overview
             15.3.8. Chembio Diagnostic Systems
                       15.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.8.2 Product Portfolio
                       15.3.8.3 SWOT Analysis
                       15.3.8.4 Financial Overview
                       15.3.8.5 Strategic Overview
             15.3.9. Danaher Corporation (Cepheid) 
                       15.3.9.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.9.2 Product Portfolio
                       15.3.9.3 SWOT Analysis
                       15.3.9.4 Financial Overview
                       15.3.9.5 Strategic Overview
             15.3.10. Becton, Dickinson and Company 
                       15.3.10.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.10.2 Product Portfolio
                       15.3.10.3 SWOT Analysis
                       15.3.10.4 Financial Overview
                       15.3.10.5 Strategic Overview
      15.4. Key Takeaways

List of Figures

Figure 01: Market Size, by Test Type (US$ Mn), 2016
Figure 02: Market Share, Top Trends by Product Type
Figure 03: Market Share by Region, 2016
Figure 04: Market Share Analysis by Region
Figure 05: Key Industry Developments
Figure 06: Porter’s Five Forces Analysis 
Figure 07: Global HIV/AIDS Diagnostics Market Size (US$ Mn) and Forecast, 2016–2025
Figure 08: Preventive Measures for HIV/AIDS
Figure 09: Global Market Value Share, by Product type (2016)
Figure 10: Global Market Value Share, by Test Type (2016)
Figure 11: Global Market Value Share, by End users (2016)
Figure 12: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025 Analysis
Figure 13: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits and Reagents, 2015–2025
Figure 14: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), Reagents, by Instruments, 2015–2025
Figure 15: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 16: HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017–2025
Figure 17: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 18: Global HIV/AIDS Diagnostic Market Revenue, by Rapid Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global HIV/AIDS Diagnostic Market Revenue, by ELISA (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global HIV/AIDS Diagnostic Market Revenue, by Nucleic Acid Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global HIV/AIDS Diagnostic Market Revenue, by Others Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017 -2025
Figure 23: Global HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 24: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 25: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Private Diagnostic Laboratories, 2015–2025 
Figure 26: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2015–2025
Figure 27: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 28: Global HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-user, 2017-2025
Figure 29: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Region, 2016 and 2025
Figure 30: Global HIV/AIDS Diagnostics Market Attractiveness Analysis, by Region, 2017–2025
Figure 31: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 32: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017 -2025
Figure 33: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 34: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 35: North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 36: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 38: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test type, 2017-2025
Figure 39: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User, 2017-2025
Figure 40: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 41: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 42: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 43: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 44: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 45: Europe HIV/AIDS Diagnostic Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017 -2025
Figure 47: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017 -2025
Figure 48: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User
Figure 49: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 50: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 51: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 52: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 53: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 54: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 55: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product type, 2017-2025
Figure 56: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017-2025
Figure 57: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User, 2017-2025
Figure 58: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 60: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 61: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 62: North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 63: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 64: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 65: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017- 2025
Figure 66: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by End Users, 2017-2025
Figure 67: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 68: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 69: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 70: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 71: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 72: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 73: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 74: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017-2025
Figure 75: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by End Users, 2017- 2025
Figure 76: Global HIV/AIDS Diagnostics Market Share Analysis, by Company (2016)

List of Tables

Table 01: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016-2025
Table 02: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 03: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 04: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Region, 2016–2025
Table 05: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 06: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016-2025
Table 07: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 08: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 09: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 10: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 11: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 12: Europe HIV/AIDS Diagnostic Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 13: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 14: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 15: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 16: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 17: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 18: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 19: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 20: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 21: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 22: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 23: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 24: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025

Global HIV/AIDS Diagnostics Market: Overview

This report provides forecast and analysis of the HIV/AIDS diagnostics market on the global and regional levels. It provides historical data of 2016 along with forecast from 2017 to 2025 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook on HIV/AIDS diagnostics globally. It includes drivers and restraints of the HIV/AIDS diagnostics market and their impact on each region during the forecast period. The report also comprises of the study of current issues with end users and opportunities for HIV/AIDS diagnostics manufacturers in the global market.

In order to provide users with comprehensive view of the market, we have included detailed competitive analysis and market players with unique selling propositions. The competitive dashboard included in the report provides detailed comparison of HIV/AIDS diagnostics manufacturers on parameters such as product offerings, revenue, key strategies, and recent developments. The study encompasses market attractiveness analysis, by product type, by test type, by end users and region.

Global HIV/AIDS Diagnostics Market: Research Methodology

Market value for global HIV/AIDS diagnostics have been estimated based on utility of HIV/AIDS diagnostics for all product types. The revenue is forecasted through regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The HIV/AIDS diagnostic market has been analyzed based on expected demand. Most of the key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been considered while estimating the market for various end users of HIV/AIDS diagnostics in different regions.

Bottom-up approach has been used to estimate the HIV/AIDS diagnostics market size, and top-down approach has been used to validate the market number. The market has been forecasted based on constant currency rates. A number of secondary sources consulted during the course of the study include Factiva, NCBI, Google books, company annual reports, websites, white papers, and publications.

Global HIV/AIDS Diagnostics Market: Segmentation

The report includes revenue generated from sales of HIV/AIDS diagnostics in all regions and important countries in the regions. By product type, the global HIV/AIDS diagnostics market has been segmented into kits and reagents, instruments and others. On the basis of test type the HIV/AIDS diagnostics market is segmented into rapid tests (POC), ELISA, nucleic acid tests and others. On the basis of end users, the global HIV/AIDS diagnostics market is segmented into hospitals, private diagnostics laboratories, academic and research institutes and others. Geographically, the market is segmented into regions viz. North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Global HIV/AIDS Diagnostics Market: Competitive Analysis

The report provides detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the key players in the global HIV/AIDS diagnostics market include Alere, Hologic, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Abbott Laboratories, Siemens Healthineers, OraSure Technologies, Inc., Chembio Diagnostic Systems etc.

The global HIV/AIDS diagnostics market is segmented as follows:

Global HIV/AIDS Diagnostics Market – By Product Type

  • Kits and Reagents
  • Instruments
  • Others

Global HIV/AIDS Diagnostics Market – By Test Type

  • Rapid Tests (POC)
  • ELISA
  • Nucleic Acid Tests
  • Others

Global HIV/AIDS Diagnostics Market – By End Users

  • Hospitals
  • Private Diagnostics Laboratories
  • Academic and Research Institutes
  • Others

Global HIV/AIDS Diagnostics Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top